|
Hans Hoogeveen is Director New Projects of Julius Clinical Research.
He studied Medical Biology at the VU University in Amsterdam, the Netherlands, and received his PhD degree from the Radiobiology/Radiotherapy Department, University Hospital (AMC) of the University of Amsterdam, the Netherlands.
After his studies, Hans Hoogeveen decided to expand his career in the field of applied clinical research. Now he has more than 15 years experience working for CROs varying from the large multinational operating CRO Parexel to niche players (NDDO Oncology and IATEC). His clinical research experience includes the field of oncology and infectious diseases. During his career within clinical research, Hans Hoogeveen worked in various positions. In his last position at IATEC, he was responsible for the global clinical trial activities in the position of Director Clinical Operations. |
